Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • Links
  • Publisher Full Text
  • Publisher Full Text
  • Authors
  • Powell K
  • MESH
  • BRCA1 Protein
  • Breast Neoplasms
  • Enzyme Inhibitors
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Genes, Tumor Suppressor
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Poly(ADP-ribose) Polymerases
  • Retinoblastoma Protein
  • Tumor Markers, Biological
  • United States

Unbound MEDLINE

Molecular oncology: The positive in the negative.

Links

  • Publisher Full Text
  • Publisher Full Text
  • Authors

    Powell K

    Source

    Nature 485:7400 2012 May 31 pg S52-3

    MeSH

    BRCA1 Protein
    Breast Neoplasms
    Enzyme Inhibitors
    Female
    Gene Expression Profiling
    Gene Expression Regulation, Neoplastic
    Genes, Tumor Suppressor
    High-Throughput Nucleotide Sequencing
    Humans
    Poly(ADP-ribose) Polymerases
    Retinoblastoma Protein
    Tumor Markers, Biological
    United States

    Pub Type(s)

    Journal Article

    Language

    eng

    PubMed ID

    22648498

    Related Citations

    • An Achilles' heel for breast cancer?
    • PARP inhibitors in BRCA1-/BRCA2-associated and triple-negative breast cancers.
    • Tailored targeted therapy for all: a realistic and worthwhile objective?
    • Debate: tailored targeted therapy for all--a realistic and worthwhile objective? Introduction to Session 2.
    • Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study.
    • PARP inhibitors: will the new class of drugs match the hype?
    • Higher cytoplasmic and nuclear poly(ADP-ribose) polymerase expression in familial than in sporadic breast cancer.
    • What's PARPing up for triple-negative breast cancer?
    More
    unbound logo
    • Home »
    • Contact Us »
    • Help »
    • Privacy / Disclaimer »
    • Terms of Service »
    • Log In »
    • twitter
    • facebook
    © 2000–2013 Unbound Medicine, Inc. All rights reserved